首页> 外文会议>Advancing methods for biomolecular crystallography >Crystallizing Membrane Proteins for Structure-Function Studies Using Lipidic Mesophases
【24h】

Crystallizing Membrane Proteins for Structure-Function Studies Using Lipidic Mesophases

机译:结晶膜蛋白用于脂质中间相的结构功能研究

获取原文
获取原文并翻译 | 示例

摘要

The lipidic cubic mesophase or in meso method for crystallizing membrane proteins has posted some high profile successes recently. This is especially true in the area of G protein-coupled receptors with over a dozen new crystallographic structures emerging in the past 5 years. Slowly, it is becoming an accepted method with a proven record and convincing generality. However, it is not a method that is used in every membrane structural biology laboratory and that is unfortunate. The reluctance in adopting it is attributable, in part, to the anticipated difficulties associated with handling the sticky, viscous cubic mesophase in which crystals grow. Harvesting and collecting diffraction data with the mesophase-grown crystals is also viewed with some trepidation. It is acknowledged that there are challenges associated with the method. However, over the years we have worked to make the method user-friendly. To this end, tools for handling the mesophase in the pico- to nanolitre volume range have been developed for efficient crystallization screening in manual and robotic modes. Glass crystallization plates have been built that provide unparalleled optical quality and sensitivity to nascent crystals. Lipid and precipitant screens have been implemented for a more rational approach to crystallogenesis such that the method can now be applied to a wide variety of membrane protein types and sizes. These assorted advances are outlined here along with a summary of the membrane proteins that have yielded to the method. The challenges that must be overcome to further develop the method are described.
机译:最近,脂质立方中间相或结晶膜蛋白的中间相方法取得了一些成功。在过去五年中出现了十几种新的晶体结构的G蛋白偶联受体领域尤其如此。慢慢地,它已成为具有公认记录和令人信服的通用性的公认方法。然而,并不是每个膜结构生物学实验室都使用这种方法,这是不幸的。不愿意采用它的部分原因是与处理晶体在其中生长的粘稠,粘稠的立方中间相有关的预期困难。中间状态生长的晶体的收集和收集衍射数据也有些令人不安。公认的是,该方法存在挑战。但是,多年来,我们一直致力于使该方法变得用户友好。为此,已经开发了用于在皮升至纳升体积范围内处理中间相的工具,以便在手动和自动模式下进行有效的结晶筛选。已建成的玻璃结晶板可提供无与伦比的光学质量和对新生晶体的敏感性。脂质和沉淀物筛查已被采用,是一种更合理的结晶发生方法,因此该方法现在可应用于多种膜蛋白类型和大小。在此概述了这些各种各样的进展,以及对该方法产生的膜蛋白的概述。描述了进一步开发该方法必须克服的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号